ClearOne (CLRO:BUY Long-Term) Revenues drop 32% YOY due to competitor products that infringe on ClearOne’s IP.

Written by Super User on 15 August 2018.

ClearOne (CLRO:BUY) Revenues fell year-over-year and sequentially due to continued slow transition to new AV conferencing platform

Written by Super User on 26 April 2018.

Control4 Corporation (CTRL:BUY) The company announced better than expected first quarter results with revenues increasing 18% to $59.1 million and EPS up 75%

Written by Super User on 29 May 2018.

Control4 Corporation (CTRL:BUY) The company announced better than expected second quarter results with revenues increasing 13%

Written by Super User on 07 September 2018.

Edgewater Technology (EDGW:DROP) EDGW shares have risen above our prior price target of $8.10.

Written by Super User on 21 April 2014.

Emergent BioSolutions (EBS:BUY Long-term) EBS agrees to acquire PaxVax, which owns revenue-generating, FDA-approved vaccines for cholera and typhoid.

Written by Super User on 15 August 2018.

Emergent BioSolutions (EBS:BUY Long-term) Q2:18 revenues rise 118% YOY as EBS completes delayed Q1 product deliveries as well as all planned Q2 deliveries.

Written by Super User on 08 August 2018.

Emergent BioSolutions (EBS:BUY) BioThrax sales disappoint in Q2:16, leading to revenue decline and net loss.

Written by Super User on 12 August 2016.

Emergent BioSolutions (EBS:BUY) Q1:18 revenues essentially flat due to delayed product deliveries, which EBS expects to complete in Q2.

Written by Super User on 08 May 2018.

EVIO, Inc. (EVIO:BUY) EVIO announced subdued Q2:18 results with revenues decreasing 12.1% to $732,311 much below our estimates.

Written by Super User on 25 May 2018.

Full House Resorts (FLL:BUY Long-term) The company announced lower than expected revenue and adjusted EBITDA versus our estimates.

Written by Super User on 06 September 2018.

Full House Resorts (FLL:BUY) The company announced subdued fourth quarter results with revenues decreasing 4.3%

Written by Super User on 18 May 2018.

General Finance Corp. (GFN:BUY Long-Term) General Finance reported another strong growth quarter in Q3:18, with revenue of $84.4 million, up 23.3%

Written by Super User on 29 May 2018.

Gladstone Land Corporation (LAND:BUY) Operating revenues improved 35.7% in Q1:18 compared to the previous quarter May 15, 2018 By Senior Analyst 29-MAR-18 – Gladstone Land Corporation (LAND:BUY) LAND significantly expanded its portfolio in FY:17 and we ex

Written by Super User on 10 May 2018.

Gladstone Land Corporation (LAND:BUY) Operating revenues improved 35.7% in Q1:18 compared to the previous quarter May 15, 2018 By Senior Analyst 29-MAR-18 – Gladstone Land Corporation (LAND:BUY) LAND significantly expanded its portfolio in FY:17 and we ex

Written by Super User on 15 May 2018.

Gladstone Land Corporation (LAND:BUY) Q2:18 operating revenues improves 23% YOY, but operating expenses rise 38%

Written by Super User on 22 August 2018.

Gray Television Network (GTN:BUY) Record-setting results in net income and cash flow for 2Q16.

Written by Super User on 10 August 2016.

Gray Television Network (GTN:NA) Dropping coverage based on limited upside in a sector facing significant headwinds due to new disruptive media technologies.

Written by Super User on 29 June 2018.

Harsco Corporation (HSC:BUY) We are impressed with HSC’s prospects amid broad based growth across its three segments.

Written by Super User on 27 August 2018.

Harvard Bioscience (HBIO:BUY) HBIO delivers a strong Q2 with 66% YOY revenue growth and 133% gains in non-GAAP EPS.

Written by Super User on 03 August 2018.

1
2
3
4